Answers are grounded in this paper and cite their sources.
Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are commonly coexisting clinical entities with still growing incidence worldwide. Recently, circulating microRNAs (miRNAs) have emerged as novel molecular players in cardiometabolic diseases. This study aimed to identify a specific miRNA signature as a candidate biomarker for CAD in T2DM and to delineate potential miRNA-dependent mechanisms contributing to diabetic atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Szydełko et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: